280 related articles for article (PubMed ID: 26917087)
1. Synergistic Effect of Cold Atmospheric Plasma and Drug Loaded Core-shell Nanoparticles on Inhibiting Breast Cancer Cell Growth.
Zhu W; Lee SJ; Castro NJ; Yan D; Keidar M; Zhang LG
Sci Rep; 2016 Feb; 6():21974. PubMed ID: 26917087
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel-Loaded Core-Shell Magnetic Nanoparticles and Cold Atmospheric Plasma Inhibit Non-Small Cell Lung Cancer Growth.
Yu H; Wang Y; Wang S; Li X; Li W; Ding D; Gong X; Keidar M; Zhang W
ACS Appl Mater Interfaces; 2018 Dec; 10(50):43462-43471. PubMed ID: 30375840
[TBL] [Abstract][Full Text] [Related]
3. Cold atmospheric plasma and iron oxide-based magnetic nanoparticles for synergetic lung cancer therapy.
Li W; Yu H; Ding D; Chen Z; Wang Y; Wang S; Li X; Keidar M; Zhang W
Free Radic Biol Med; 2019 Jan; 130():71-81. PubMed ID: 30342190
[TBL] [Abstract][Full Text] [Related]
4. Docetaxel-loaded nanoparticles based on star-shaped mannitol-core PLGA-TPGS diblock copolymer for breast cancer therapy.
Tao W; Zeng X; Liu T; Wang Z; Xiong Q; Ouyang C; Huang L; Mei L
Acta Biomater; 2013 Nov; 9(11):8910-20. PubMed ID: 23816645
[TBL] [Abstract][Full Text] [Related]
5. Low-molecular-weight protamine-modified PLGA nanoparticles for overcoming drug-resistant breast cancer.
Wang H; Zhao Y; Wang H; Gong J; He H; Shin MC; Yang VC; Huang Y
J Control Release; 2014 Oct; 192():47-56. PubMed ID: 25003794
[TBL] [Abstract][Full Text] [Related]
6. Alendronate coated poly-lactic-co-glycolic acid (PLGA) nanoparticles for active targeting of metastatic breast cancer.
Thamake SI; Raut SL; Gryczynski Z; Ranjan AP; Vishwanatha JK
Biomaterials; 2012 Oct; 33(29):7164-73. PubMed ID: 22795543
[TBL] [Abstract][Full Text] [Related]
7. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells.
Yallapu MM; Gupta BK; Jaggi M; Chauhan SC
J Colloid Interface Sci; 2010 Nov; 351(1):19-29. PubMed ID: 20627257
[TBL] [Abstract][Full Text] [Related]
8. A rationally designed photo-chemo core-shell nanomedicine for inhibiting the migration of metastatic breast cancer cells followed by photodynamic killing.
Malarvizhi GL; Chandran P; Retnakumari AP; Ramachandran R; Gupta N; Nair S; Koyakutty M
Nanomedicine; 2014 Apr; 10(3):579-87. PubMed ID: 24200524
[TBL] [Abstract][Full Text] [Related]
9. A polymer-protein core-shell nanomedicine for inhibiting cancer migration followed by photo-triggered killing.
Ramachandran R; Malarvizhi GL; Chandran P; Gupta N; Menon D; Panikar D; Nair S; Koyakutty M
J Biomed Nanotechnol; 2014 Aug; 10(8):1401-15. PubMed ID: 25016641
[TBL] [Abstract][Full Text] [Related]
10. The tumor accumulation and therapeutic efficacy of doxorubicin carried in calcium phosphate-reinforced polymer nanoparticles.
Min KH; Lee HJ; Kim K; Kwon IC; Jeong SY; Lee SC
Biomaterials; 2012 Aug; 33(23):5788-97. PubMed ID: 22591612
[TBL] [Abstract][Full Text] [Related]
11. Biodegradable self-assembled nanoparticles of poly (D,L-lactide-co-glycolide)/hyaluronic acid block copolymers for target delivery of docetaxel to breast cancer.
Huang J; Zhang H; Yu Y; Chen Y; Wang D; Zhang G; Zhou G; Liu J; Sun Z; Sun D; Lu Y; Zhong Y
Biomaterials; 2014 Jan; 35(1):550-66. PubMed ID: 24135268
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Liu Y; Pan J; Feng SS
Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronic acid-decorated poly(lactic-co-glycolic acid) nanoparticles for combined delivery of docetaxel and tanespimycin.
Pradhan R; Ramasamy T; Choi JY; Kim JH; Poudel BK; Tak JW; Nukolova N; Choi HG; Yong CS; Kim JO
Carbohydr Polym; 2015 Jun; 123():313-23. PubMed ID: 25843864
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R
Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630
[TBL] [Abstract][Full Text] [Related]
15. Synergistic inhibition of breast cancer by co-delivery of VEGF siRNA and paclitaxel via vapreotide-modified core-shell nanoparticles.
Feng Q; Yu MZ; Wang JC; Hou WJ; Gao LY; Ma XF; Pei XW; Niu YJ; Liu XY; Qiu C; Pang WH; Du LL; Zhang Q
Biomaterials; 2014 Jun; 35(18):5028-38. PubMed ID: 24680191
[TBL] [Abstract][Full Text] [Related]
16. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
17. Poly(D, L-lactide-co-glycolide)/montmorillonite nanoparticles for improved oral delivery of exemestane.
Li Z; Liu K; Sun P; Mei L; Hao T; Tian Y; Tang Z; Li L; Chen D
J Microencapsul; 2013; 30(5):432-40. PubMed ID: 23517067
[TBL] [Abstract][Full Text] [Related]
18. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
[TBL] [Abstract][Full Text] [Related]
19. Radiosensitization of TPGS-emulsified docetaxel-loaded poly(lactic-co-glycolic acid) nanoparticles in CNE-1 and A549 cells.
Shi W; Yuan Y; Chu M; Zhao S; Song Q; Mu X; Xu S; Zhang Z; Yang K
J Biomater Appl; 2016 Mar; 30(8):1127-41. PubMed ID: 26608458
[TBL] [Abstract][Full Text] [Related]
20. Novel nanosystem to enhance the antitumor activity of lapatinib in breast cancer treatment: Therapeutic efficacy evaluation.
Huo ZJ; Wang SJ; Wang ZQ; Zuo WS; Liu P; Pang B; Liu K
Cancer Sci; 2015 Oct; 106(10):1429-37. PubMed ID: 26177628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]